U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 7842

1.
Progress in Antibiotics
Br Med J. 1953 Nov 7; 2(4844): 1035.
PMCID:
PMC2030012
SummaryPage BrowsePDF–183K
2.
Unique Mode of Cell Division by the Mycobacterial Genetic Resister Clones Emerging De Novo from the Antibiotic-Surviving Population
Kishor Jakkala, Avraneel Paul, Atul Pradhan, Rashmi Ravindran Nair, Deepti Sharan, Sharmada Swaminath, Parthasarathi Ajitkumar
mSphere. 2020 Nov-Dec; 5(6): e00994-20. Published online 2020 Nov 18. doi: 10.1128/mSphere.00994-20
PMCID:
PMC7677009
AbstractArticlePDF–6.7M
3.
Therapeutic Efficacy of Poly(dl-Lactide-Co-Glycolide)-Encapsulated Antitubercular Drugs against Mycobacterium tuberculosis Infection Induced in Mice
Manisha Dutt, G. K. Khuller
Antimicrob Agents Chemother. 2001 Jan; 45(1): 363–366. doi: 10.1128/AAC.45.1.363-366.2001
PMCID:
PMC90295
AbstractArticlePDF–120K
4.
A Case of Pseudomembranous Colitis Associated with Rifampin
Ji Young Park, Joon Seok Kim, Sun Jong Jeung, Myung Sook Kim, Seok Chan Kim
Korean J Intern Med. 2004 Dec; 19(4): 261–265. doi: 10.3904/kjim.2004.19.4.261
PMCID:
PMC4531579
AbstractArticlePDF–338K
5.
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients
A Wanchu, A Bhatnagar, M Khullar, A Sud, P Bambery, S Singh
BMC Infect Dis. 2002; 2: 15. Published online 2002 Jul 29. doi: 10.1186/1471-2334-2-15
PMCID:
PMC119853
AbstractArticlePDF–245K
6.
Modification of Rifamycin Polyketide Backbone Leads to Improved Drug Activity against Rifampicin-resistant Mycobacterium tuberculosis
Aeshna Nigam, Khaled H. Almabruk, Anjali Saxena, Jongtae Yang, Udita Mukherjee, Hardeep Kaur, Puneet Kohli, Rashmi Kumari, Priya Singh, Lev N. Zakharov, Yogendra Singh, Taifo Mahmud, Rup Lal
J Biol Chem. 2014 Jul 25; 289(30): 21142–21152. Published online 2014 Jun 12. doi: 10.1074/jbc.M114.572636
PMCID:
PMC4110317
AbstractArticlePDF–1.8M
7.
Nanosized Drug Delivery Systems to Fight Tuberculosis
Tom Bourguignon, Jesus Alfredo Godinez-Leon, Ruxandra Gref
Pharmaceutics. 2023 Feb; 15(2): 393. Published online 2023 Jan 24. doi: 10.3390/pharmaceutics15020393
PMCID:
PMC9964171
AbstractArticlePDF–5.1M
8.
Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: In vitro, molecular docking and in-silico drug likeliness studies
Surendra Babu Lagu, Rajendra Prasad Yejella, Srinath Nissankararao, Richie R. Bhandare, Venu Sampath Golla, Bontha Venkata Subrahmanya Lokesh, M. Mukhlesur Rahman, Afzal Basha Shaik
PLoS One. 2022; 17(6): e0265068. Published online 2022 Jun 16. doi: 10.1371/journal.pone.0265068
PMCID:
PMC9202851
AbstractArticlePDF–1.5M
9.
The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles
Helena I. Boshoff, Neha Malhotra, Clifton E. Barry, III, Sangmi Oh
Pharmaceuticals (Basel) 2024 Feb; 17(2): 211. Published online 2024 Feb 6. doi: 10.3390/ph17020211
PMCID:
PMC10892018
AbstractArticlePDF–6.2M
10.
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
Levin Thomas, Sumit Raosaheb Birangal, Rajdeep Ray, Sonal Sekhar Miraj, Murali Munisamy, Muralidhar Varma, Chidananda Sanju S.V., Mithu Banerjee, Gautham G. Shenoy, Mahadev Rao
Ther Adv Drug Saf. 2021; 12: 20420986211041277. Published online 2021 Aug 26. doi: 10.1177/20420986211041277
PMCID:
PMC8404633
AbstractArticlePDF–2.3M
11.
Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis
RJ Svensson, USH Simonsson
CPT Pharmacometrics Syst Pharmacol. 2016 May; 5(5): 264–273. Published online 2016 May 17. doi: 10.1002/psp4.12079
PMCID:
PMC4873565
AbstractArticlePDF–492K
12.
A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations
Alexander D. Giddey, Elise de Kock, Kehilwe C. Nakedi, Shaun Garnett, Andrew J. M. Nel, Nelson C. Soares, Jonathan M. Blackburn
Sci Rep. 2017; 7: 43858. Published online 2017 Mar 6. doi: 10.1038/srep43858
PMCID:
PMC5338346
AbstractArticlePDF–1.0M
13.
Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era
Alina Minias, Lidia Żukowska, Ewelina Lechowicz, Filip Gąsior, Agnieszka Knast, Sabina Podlewska, Daria Zygała, Jarosław Dziadek
Front Microbiol. 2020; 11: 618168. Published online 2021 Feb 2. doi: 10.3389/fmicb.2020.618168
PMCID:
PMC7884339
AbstractArticlePDF–1.6M
14.
Disseminated tuberculosis in an HIV-infected child: rifampicin resistance detected by GeneXpert in a lymph node aspirate but not in cerebrospinal fluid
Anna Gamell, Alex John Ntamatungiro, Manuel Battegay, Emilio Letang
BMJ Case Rep. 2015; 2015: bcr2014207997. Published online 2015 Aug 3. doi: 10.1136/bcr-2014-207997
PMCID:
PMC4533660
AbstractArticlePDF–316K
15.
Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicin
Chao Zhang, Paolo Denti, Eric Decloedt, Gary Maartens, Mats O Karlsson, Ulrika S H Simonsson, Helen McIlleron
Br J Clin Pharmacol. 2012 May; 73(5): 758–767. Published online 2011 Nov 30. doi: 10.1111/j.1365-2125.2011.04154.x
PMCID:
PMC3403203
AbstractArticlePDF–1.2M
16.
Tandem LC-MS Identification of Antitubercular Compounds in Zones of Growth Inhibition Produced by South African Filamentous Actinobacteria
Daniel J. Watson, Lubbe Wiesner, Tlhalefo Matimela, Denzil Beukes, Paul R. Meyers
Molecules. 2023 Jun; 28(11): 4276. Published online 2023 May 23. doi: 10.3390/molecules28114276
PMCID:
PMC10254512
AbstractArticlePDF–4.2M
17.
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives
Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb, Melendhran Pillay, Bashaer Abu-Irmaileh, Yasser Bustanji, Sandeep Chandrashekharappa, Christophe Tratrat, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Pottathil Shinu, Michelyne Haroun, Mahmoud Kandeel, Abdulmalek Ahmed Balgoname, Rashmi Venugopala, Mohamed A. Morsy
Antibiotics (Basel) 2022 Jul; 11(7): 831. Published online 2022 Jun 21. doi: 10.3390/antibiotics11070831
PMCID:
PMC9311641
AbstractArticlePDF–4.7M
18.
Synthesis, Molecular Docking Study, and Biological Evaluation of New 4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N’-(2-(substituted)acetyl)benzohydrazides as Dual Enoyl ACP Reductase and DHFR Enzyme Inhibitors
Mater H. Mahnashi, Pooja Koganole, Prem Kumar S. R., Sami S. Ashgar, Ibrahim Ahmed Shaikh, Shrinivas D. Joshi, Ali S. Alqahtani
Antibiotics (Basel) 2023 Apr; 12(4): 763. Published online 2023 Apr 16. doi: 10.3390/antibiotics12040763
PMCID:
PMC10135272
AbstractArticlePDF–2.7M
19.
Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy
Sultan Tousif, Dhiraj Kumar Singh, Sitabja Mukherjee, Shaheer Ahmad, Rakesh Arya, Ranjan Nanda, Anand Ranganathan, Maitree Bhattacharyya, Luc Van Kaer, Santosh K. Kar, Gobardhan Das
Front Immunol. 2017; 8: 739. Published online 2017 Jun 30. doi: 10.3389/fimmu.2017.00739
PMCID:
PMC5491555
AbstractArticlePDF–1.6M
20.
The Role of Metallic Nanoparticles in Inhibition of Mycobacterium Tuberculosis and Enhances Phagosome Maturation into the Infected Macrophage
Alireza Jafari, Atabak Nagheli, Ali Alavi Foumani, Bahram Soltani, Raj Goswami
Oman Med J. 2020 Nov; 35(6): e194. Published online 2020 Nov 12. doi: 10.5001/omj.2020.78
PMCID:
PMC7658918
AbstractArticlePDF–920K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center